These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 24577512

  • 1. Tandem triplication of the BCL2 gene in CD5-positive intravascular large B cell lymphoma with bone marrow involvement.
    Yamamoto K, Okamura A, Yakushijin K, Hayashi Y, Matsuoka H, Minami H.
    Ann Hematol; 2014 Oct; 93(10):1791-3. PubMed ID: 24577512
    [No Abstract] [Full Text] [Related]

  • 2. Intravascular large B-cell lymphoma--a diagnostic dilemma.
    Ramkumar B, Hutchison R, Khadim H, Gajra A.
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e18-21. PubMed ID: 24060286
    [No Abstract] [Full Text] [Related]

  • 3. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
    Yi SH, Xu Y, Zou DH, An G, Zhao YZ, Qi JY, Qiu LG.
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
    [Abstract] [Full Text] [Related]

  • 4. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney].
    Sagüés M, Paredes V, Altés J, Fernández de Sevilla A.
    Med Clin (Barc); 2015 Jan 06; 144(1):48-9. PubMed ID: 24698716
    [No Abstract] [Full Text] [Related]

  • 5. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A, Gozzetti A, Rigacci L.
    Cancer; 2011 Aug 01; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract] [Full Text] [Related]

  • 6. Patient with high-grade fever, night sweats, and hepatosplenomegaly.
    Müldür E, Chott A, Mirzaei S, Zojer N, Ludwig H.
    J Clin Oncol; 2011 Apr 01; 29(10):e254-6. PubMed ID: 21220615
    [No Abstract] [Full Text] [Related]

  • 7. Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.
    Scandurra M, Mian M, Greiner TC, Rancoita PM, De Campos CP, Chan WC, Vose JM, Chigrinova E, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Montes-Moreno S, Piris MA, Facchetti F, Tucci A, Nomdedeu JF, Lazure T, Lambotte O, Uccella S, Pinotti G, Pruneri G, Martinelli G, Young KH, Tibiletti MG, Rinaldi A, Zucca E, Kwee I, Bertoni F.
    Br J Haematol; 2010 Nov 01; 151(3):221-31. PubMed ID: 20813005
    [Abstract] [Full Text] [Related]

  • 8. Double-hit diffuse large B-cell lymphoma.
    Friedberg JW.
    J Clin Oncol; 2012 Oct 01; 30(28):3439-43. PubMed ID: 22949152
    [No Abstract] [Full Text] [Related]

  • 9. Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Testoni M, Kwee I, Greiner TC, Montes-Moreno S, Vose J, Chan WC, Chiappella A, Baldini L, Ferreri AJ, Gaidano G, Mian M, Zucca E, Bertoni F.
    Br J Haematol; 2011 Oct 01; 155(2):274-7. PubMed ID: 21488860
    [No Abstract] [Full Text] [Related]

  • 10. Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study.
    Deisch J, Fuda FB, Chen W, Karandikar N, Arbini AA, Zhou XJ, Wang HY.
    Arch Pathol Lab Med; 2009 Sep 01; 133(9):1477-82. PubMed ID: 19722759
    [Abstract] [Full Text] [Related]

  • 11. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.
    Stefancikova L, Moulis M, Fabian P, Vasova I, Zedek F, Ravcukova B, Muzik J, Kuglik P, Vranova V, Falkova I, Hrabalkova R, Smardova J.
    Int J Oncol; 2011 Dec 01; 39(6):1413-20. PubMed ID: 21874232
    [Abstract] [Full Text] [Related]

  • 12. Hope for very elderly patients with diffuse large B-cell lymphoma.
    Ribera JM.
    Lancet Oncol; 2011 May 01; 12(5):412-3. PubMed ID: 21482185
    [No Abstract] [Full Text] [Related]

  • 13. [Case of peritubular capillary dominant intravascular large B-cell lymphoma (PTC dominant IVLBCL) successfully treated with chemotherapy].
    Kado H, Hatta T, Ueno R, Takagi A, Segawa H, Sawada K, Hosokawa Y.
    Nihon Jinzo Gakkai Shi; 2011 May 01; 53(7):1046-52. PubMed ID: 22073871
    [Abstract] [Full Text] [Related]

  • 14. [Interest of an intensive chemotherapy for intravascular large B cell lymphoma].
    Baldolli A, Chuffart M, Geffray L, Verneuil L, Reman O.
    Bull Cancer; 2013 Apr 01; 100(4):317-21. PubMed ID: 23587663
    [Abstract] [Full Text] [Related]

  • 15. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
    Park YH, Sohn SK, Kim JG, Lee MH, Song HS, Kim MK, Jung JS, Lee JJ, Kim HJ, Kim DH.
    Clin Cancer Res; 2009 Mar 15; 15(6):2107-15. PubMed ID: 19276283
    [Abstract] [Full Text] [Related]

  • 16. MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
    Perry AM, Alvarado-Bernal Y, Laurini JA, Smith LM, Slack GW, Tan KL, Sehn LH, Fu K, Aoun P, Greiner TC, Chan WC, Bierman PJ, Bociek RG, Armitage JO, Vose JM, Gascoyne RD, Weisenburger DD.
    Br J Haematol; 2014 May 15; 165(3):382-91. PubMed ID: 24506200
    [Abstract] [Full Text] [Related]

  • 17. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A, Boggiani D, Panebianco M, Vasini G, Salvagni S, Franciosi V, Ardizzoni A.
    Cancer; 2011 Mar 01; 117(5):964-73. PubMed ID: 20960528
    [Abstract] [Full Text] [Related]

  • 18. Front-line management of diffuse large B cell lymphoma.
    Cabanillas F.
    Curr Opin Oncol; 2010 Nov 01; 22(6):642-5. PubMed ID: 20811278
    [Abstract] [Full Text] [Related]

  • 19. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A, Fujimi A, Kanisawa Y, Matsuno T, Okuda T, Minami S, Doi T, Ishikawa K, Uemura N, Jyomen Y, Tomaru U.
    Gan To Kagaku Ryoho; 2013 Dec 01; 40(13):2589-92. PubMed ID: 24335377
    [Abstract] [Full Text] [Related]

  • 20. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A.
    Am J Hematol; 2012 Oct 01; 87(10):988-95. PubMed ID: 23001911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.